Inflammation but Not Endothelial Dysfunction Is Associated with the Severity of Coronary Artery Disease in Dyslipidemic Subjects

Table 2

Permanent medication usage in dyslipidemic subjects with (+CAD) and without (−CAD) coronary artery disease.

	−CAD (𝑛=69)	+CAD (𝑛=34)
Medication	Permanent usage %	Permanent usage %
ACEIs	17.4	32.4
Aspirin	21.7	73.5*
NSAI	26.1	17.6
CCA	7.2	26.5*
Beta blockers	4.3	61.8*
Digoxin	1.4	2.9
Furosemide	2.9	0.0
Hydrochlorothiazide	2.9	8.8
clopidogrel	0.0	2.9

ACEIs: Angiotensin-converting enzyme inhibitors, NSAI: Nonsteroidal anti-inflammatory agents, CCA: Calcium channel antagonists, *: 𝑃<.005 versus –EC.